| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/04/2003 | US6528019 Measuring transformer for detecting hydrocarbons in gases |
| 03/04/2003 | US6527933 Biotin-tagged DNA samples are captured at the spots of avidin immoblized on filter membrane by biotin-avidin bonding |
| 03/04/2003 | US6527438 Aggregate dilatometer device and methods of testing |
| 03/04/2003 | US6526828 Sensitive and selective method and device for the detection of trace amounts of a substance |
| 03/04/2003 | US6526805 Apparatus for continuously determining volatile substances dissolved in insulating fluid |
| 03/04/2003 | US6526803 Apparatus and method for generating moisture standards in gases |
| 03/04/2003 | US6526802 Portable breath test simulator |
| 03/04/2003 | US6526801 Method of compensating for drift in gas sensing equipment |
| 03/04/2003 | CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 03/03/2003 | WO2002025274A1 Reaction detecting method, immunoreaction detecting method and device |
| 03/03/2003 | CA2421217A1 Reaction detecting method, immunoreaction detecting method and device |
| 03/03/2003 | CA2400893A1 Gas sensor |
| 02/28/2003 | CA2494895A1 Process for manufacturing an analytical device containing lancet and test element |
| 02/28/2003 | CA2400601A1 Real-time gene quantification with internal standards |
| 02/28/2003 | CA2400521A1 Gpcr subfamily sequence motifs, and methods for gpcr characterization |
| 02/28/2003 | CA2399890A1 Analytical device with lancet and test element |
| 02/28/2003 | CA2356499A1 Methods and compositions relating to phosphorylated myosin light chain 1 |
| 02/27/2003 | WO2003017177A2 Method and system for profiling biological systems |
| 02/27/2003 | WO2003017138A1 Biological sequence information reading method and storing method |
| 02/27/2003 | WO2003017127A2 Method for modelling biochemical pathways |
| 02/27/2003 | WO2003017048A2 A method of screening for disorders of glucose metabolism |
| 02/27/2003 | WO2003017042A2 System and method for environmental data acquisition |
| 02/27/2003 | WO2003016917A2 Sodium channel regulators and modulators |
| 02/27/2003 | WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016913A1 Suppression of cross-reactivity and non-specific binding by antibodies using protein a |
| 02/27/2003 | WO2003016912A2 'lab on chip' from photoresist material for medic al diagnostic applications |
| 02/27/2003 | WO2003016911A1 Carrier for immobilized biomolecules and method for biomolecule immobilization |
| 02/27/2003 | WO2003016910A1 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 02/27/2003 | WO2003016909A1 Method for determining protein component in a biological sample |
| 02/27/2003 | WO2003016907A1 Reagent for assaying laminin 5 antigen in biological sample and assay method |
| 02/27/2003 | WO2003016906A1 Method of diagnosing or monitoring saccharometabolic error |
| 02/27/2003 | WO2003016905A2 Determination of t-cell/mayor histocompatibility complex (mhc) reactivity |
| 02/27/2003 | WO2003016904A2 Peptide sequence tags and method of using same |
| 02/27/2003 | WO2003016903A2 Device and method for determining an analyte |
| 02/27/2003 | WO2003016902A1 Diagnostic testing process and apparatus |
| 02/27/2003 | WO2003016901A1 Sensor for detecting biomolecule using carbon nanotubes |
| 02/27/2003 | WO2003016900A2 Method and system for determining the type of fuel used to power a vehicle |
| 02/27/2003 | WO2003016899A2 Method and system for detection of hydrocarbon species in a gas |
| 02/27/2003 | WO2003016894A2 Coplanar waveguide biosensor for detecting molecular or cellular events |
| 02/27/2003 | WO2003016887A2 Method for analyzing cellular events in a sample by measuring transmitted and/or reflected electromagnetic test signals in a frequency range from 500 khz to 1000 ghz |
| 02/27/2003 | WO2003016883A1 A method of measuring solubility |
| 02/27/2003 | WO2003016877A1 Method of compensating a mos gas sensor, method of manufacturing a mos gas sensor, mos gas sensor, and fuel cell system |
| 02/27/2003 | WO2003016876A1 Improvements to accelerated artificial weathering test systems |
| 02/27/2003 | WO2003016875A2 Flow-cytometric axial pattern analysis of multicellular organisms |
| 02/27/2003 | WO2003016872A1 Process and apparatus for preparing and presenting a tissue sample for histological study |
| 02/27/2003 | WO2003016871A1 Assay device for evaluating entrainable substances |
| 02/27/2003 | WO2003016867A2 Method and quantification assay for determining c-kit/scf/pakt status |
| 02/27/2003 | WO2003016866A2 Method for the enumeration of mammalian micronucleated erythrocyte populations with a single-laser flow cytometer |
| 02/27/2003 | WO2003016861A2 Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| 02/27/2003 | WO2003016860A2 Systems and methods for screening pharmaceutical chemicals |
| 02/27/2003 | WO2003016858A2 Method and apparatus for selective biological material detection |
| 02/27/2003 | WO2003016575A1 Method for characterizing autoimmune disorders |
| 02/27/2003 | WO2003016573A1 Age-associated markers |
| 02/27/2003 | WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 02/27/2003 | WO2003016566A2 Improvements relating to capillary gel array analysis |
| 02/27/2003 | WO2003016560A2 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 02/27/2003 | WO2003016556A1 Measurement of microbiological activity in an opaque medium |
| 02/27/2003 | WO2003016555A1 Cell diagnosing method, and device and apparatus used for it |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016530A1 Novel protein and its dna |
| 02/27/2003 | WO2003016529A1 Novel blomia tropicalis antigens and uses therefor |
| 02/27/2003 | WO2003016528A2 Oligonucleotide compositions and their use to induce apoptosis |
| 02/27/2003 | WO2003016522A2 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | WO2003016516A2 Kinase crystal structures and materials and methods for kinase activation |
| 02/27/2003 | WO2003016514A1 Mullerian inhibiting substance levels and ovarian response |
| 02/27/2003 | WO2003016513A1 Epstein-barr virus-negative nk cell line |
| 02/27/2003 | WO2003016506A2 Secreted proteins |
| 02/27/2003 | WO2003016504A2 Polymorphisms associated with ion-channel disease |
| 02/27/2003 | WO2003016495A2 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 02/27/2003 | WO2003016493A2 Transporters and ion channels |
| 02/27/2003 | WO2003016491A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | WO2003016488A2 Cell separation system |
| 02/27/2003 | WO2003016485A2 Full-length serine protein kinase in brain and pancreas |
| 02/27/2003 | WO2003016484A2 Gleason grade 4/5 prostate cancer genes |
| 02/27/2003 | WO2003016471A2 Periostin-based diagnostic assays |
| 02/27/2003 | WO2003016466A2 ANTI-Aβ ANTIBODIES |
| 02/27/2003 | WO2003016464A2 Cancer specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016355A1 Pre-t cell receptor (pre-tcr) and the characterisation and regulation of the expression and function thereof during the development of t cells in humans |
| 02/27/2003 | WO2003016354A2 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | WO2003016353A1 Anti-ciguatoxin monoclonal antibody |
| 02/27/2003 | WO2003016352A1 Monoclonal antibodies against fungi and methods for their use |
| 02/27/2003 | WO2003016344A2 Use of lung carcinoma antigen |
| 02/27/2003 | WO2003016338A1 Crystal structure of the btk kinase domain |
| 02/27/2003 | WO2003016333A2 Virus coat protein/receptor chimeras and methods of use |
| 02/27/2003 | WO2003016328A1 Methods for the treatment and prevention of cancer |
| 02/27/2003 | WO2003016061A1 Water content sensing system for ink/water emulsion of lithographic printing press |
| 02/27/2003 | WO2003016040A1 Membrane mimetic architectures on nanoporous materials |
| 02/27/2003 | WO2003015922A1 Laminated microarray interface device |
| 02/27/2003 | WO2003015871A2 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption |
| 02/27/2003 | WO2003015832A1 Diagnostic agent for pancreatic exocrine function |
| 02/27/2003 | WO2003015829A2 Methods of determining the effects of toxins |
| 02/27/2003 | WO2003015819A1 Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 02/27/2003 | WO2003015818A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 02/27/2003 | WO2003015810A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 02/27/2003 | WO2003015768A2 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 02/27/2003 | WO2003015716A2 Immunoglobulin e vaccines and methods of use thereof |
| 02/27/2003 | WO2003015703A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
| 02/27/2003 | WO2003015697A2 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | WO2003015693A2 Screening and therapeutic methods for promoting wakefulness and sleep |